Using a flow cytometry-based assay, the potential of 106 Nef clones (isolated from patients in early infection) to downregulate Ser5 in a CEM (acute lymphoblastic leukemia T-lymphoblast) -derived CD4+ T-cell line was evaluated in order to test their hypothesis (41). This evidence concerns the gene CD4 and infection.